Merck & Co Inc (MRK)

MRK (NYSE:Drugs)
$56.80
pos +0.06
+0.11%
Today's Range: 56.28 - 57.12 | MRK Avg Daily Volume: 8,641,900
Last Update: 08/01/14 - 4:01 PM EDT
Volume: 9,987,144
YTD Performance: 13.37%
Open: $56.58
Previous Close: $56.74
52 Week Range: $44.62 - $59.84
Oustanding Shares: 2,922,376,244
Market Cap: 169,731,612,252
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 1
Hold 6 7 8 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.08 2.14 2.04
Latest Dividend: 0.44
Latest Dividend Yield: 3.03%
Dividend Ex-Date: 09/11/14
Price Earnings Ratio: 24.51
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
24.51 30.60 28.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-3.11% 17.79% 66.25%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.80 -0.04 -0.01
Net Income -28.30 3.60 0.65
EPS -26.70 4.32 0.74
Earnings for MRK:
EBITDA 14.65B
Revenue 44.03B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.88 $0.90 $3.49 $3.66
Number of Analysts 7 6 11 10
High Estimate $0.93 $0.95 $3.52 $3.77
Low Estimate $0.86 $0.85 $3.44 $3.40
Prior Year $0.92 $0.88 $3.49 $3.49
Growth Rate (Year over Year) -4.35% 2.65% 0.10% 4.62%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Something worrisome has me fretting more than I have in a while.

This Morning's Market Setup Real Money Pro($)

Where it began.
If you're worried about these moves, it's time to cash out.
If you don't like speculation, just hike the margin requirement.
Cisco, Merck and Intel earn approval from two rigorous stock-picking strategies.
Here are several themes that are still working -- and now you can get in at a bargain.
A wave of M&A in the health sector makes sense.
Standing still is no longer an option.
Shares of the top Dow performers since 16,000 still reflect leaner times.
It helps to understand how the market digests different fears.

Columnist Conversations

Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
Lang:
Last year saw the MC NYSE oscillator hit -300 on about five occasions, and each time a massive bounce ensued. ...
If you are in the NYC area, Bob Lang and I will be in town this Monday and Tuesday night. We'd love to grab a ...
There are no signals in IWM....Still watching zone 2 in WYNN for a potential entry. The updated chart is below...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.